Tirzepatide promotes weight loss by suppressing appetite and enhancing feelings of fullness. It also improves insulin sensitivity, helping to regulate blood sugar levels and boost metabolism.

Tirzepatide can result in significant weight loss, improved blood sugar control, reduced appetite, and enhanced overall metabolic health. It may also reduce risks related to obesity, like heart disease and type 2 diabetes.

Common side effects include nausea, vomiting, diarrhea, and reduced appetite. Some people may experience more severe side effects like pancreatitis or allergic reactions. It's essential to consult a healthcare provider to assess personal risks.

You can cancel your subscription at any time by emailing us at careteam@TeleDocSolutions.com or by giving us a call. It's that simple.

Absolutely, all medications are meticulously crafted in State Board of Pharmacy licensed sterile compounding pharmacies, or FDA-licensed 503(b) Outsourcing Facilities. Our partnerships span across pharmacies licensed in all 50 states, ensuring utilization of solely the finest quality ingredients.

Individual weight loss results can vary due to a range of factors, but on average, TeleDoc Meds clients typically achieve a weight loss of approximately 5% of their initial body weight. Over a 12-week period, this figure can increase to as much as 10%. For instance, someone weighing 200 pounds may expect to lose between 10-20 pounds. It's important to recognize that each person's journey is unique, and sustained success often involves making lifestyle and dietary adjustments.
Healthy weight loss is generally considered to be around 1-2 pounds per week, as rapid weight loss is not advisable from a medical standpoint.

In general, most clients typically receive their medication within 5-8 business days from their initial consultation with their provider.

Please refer to the instructional video here on how to perform a subcutaneous injection. If you encounter any difficulties or have questions, always consult your provider or a licensed medical professional for assistance.

For GLP-1 programs, patients must be at least 18 years old and no older than 75. For weight management programs, patients must be at least 18 years old and no older than 70.

Individuals with a history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia syndrome type 2 (MEN2), or severe gastrointestinal disorders should avoid Tirzepatide. It's also not recommended for those who are pregnant or breastfeeding.

To begin using Tirzepatide, schedule a consultation with one of our licensed healthcare providers at TeleDoc. We will evaluate your health profile and determine if Tirzepatide is the right option for you.

Feel free to ask if you have more specific questions or need additional information!